INNOTHERA's essential contributions

Diovenor 600® - One time per day

Launched in 1995, Diovenor 600® one per day is the first veinotonic to offer simplified dosage, facilitating observance and patient comfort. With a dosage of one tablet per day instead of several tablets in two daily doses, the product constitutes a real therapeutic advance, hailed by health professionals and patients – proof of which is that sales of the product multiplied by a factor of 2.5 in the space of 12 months.

Tubulcus®

Indicated in the treatment of venous ulcers of the lower limbs, Tubulcus® is elastic compression orthosis, knitted in a tubular shape, without a heel and opentoed. Used as a replacement for bandages, whose application is often difficult or incorrect, Tubulcus® is an innovative and effective principle because it exerts appropriate pressure that is stable over time, without relying on the skill of the fitter (who is often the patient himself). The benefit for patients is real, since healing is achieved with improved comfort and reduced treatment time.

More generally, an accumulation of knowledge and expertise in the field of textiles over the years has allowed INNOTHERA’s engineers to develop new products that combine effectiveness, comfort, and esthetics. An example of this expertise is the F.I.P. process, first marketed in September 2007, which will enable Innothera to sell new stocking profiles that exert less pressure on the foot. This new process facilitates fitting and improves patient comfort, without reducing the clinical effectiveness of the stocking. This expertise took concrete form in 2002 with the Cristal line.This expertise took concrete form in 2002 with the Cristal line.

Ideos®

Ideos® was the first fixed association of calcium and vitamin D in Europe, indicated for the correction of associated deficiencies in elderly patients. Ideos® is indicated in association with the specific treatment of osteoporosis. The fixed association, in the form of chewable tablet, was a real advance compared to earlier treatments, which were most often in the form of drops. Approved first in Europe following the Mutual Recognition Procedure, the product was then adopted by many other markets. It is now marketed in 56 countries.

Arteritis of the lower limbs
Heavy legs
Edema of the lower extremities
Varicose veins of the lower
extremities

Asthma
Chronic bronchitis
Middle-ear inflammation
Rhinitis
Sinusitis

Anxiety
Depression
Insomnia
Nervousness
Obesity
Other psychic complaints
Reaction to stressful situations

Lower genital infections
Contraception
Menopause

Fatigue, asthenia
Anemia

Eczema

Constipation
Epigastralgia
Abdominal complaints
Pyrosis, reflux
Colic syndrome

Prostate hypertrophy

Arthropathy - periarthropathy
Arthrosis
Neck pain
Painful shoulder
Hyperuricemia
Lumbar pain
Asteoporosis
Sciatica

Headache
Neuritis - neuralgia
Vertigo, dizziness